🏅 FDA Orphan Designation
Roferon A
Interferon alfa-2a
Manufacturer: Hoffmann-La Roche, Inc.
Indicated for:
Chronic myeloid leukemiaOrphan
FDA-Approved Indications (1)
Chronic myeloid leukemiaOrphan Designation
Treatment of chronic myelogenous leukemia.
Indications & Usage
Treatment of chronic myelogenous leukemia.
💙 Support Programs
View all →Roferon A
Hoffmann-La Roche, Inc.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.